The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
The Linear Programming via Regularized Least Squares (LPPinv) is a two-stage estimation method that reformulates linear programs as structured least-squares problems. Based on the Convex Least Squares Programming (CLSP) framework, LPPinv solves linear inequality, equality, and bound constraints by (1) constructing a canonical constraint system and computing a pseudoinverse projection, followed by (2) a convex-programming correction stage to refine the solution under additional regularization (e.g., Lasso, Ridge, or Elastic Net). LPPinv is intended for underdetermined and ill-posed linear problems, for which standard solvers fail.
| Version: | 0.1.0 |
| Depends: | R (≥ 4.2) |
| Imports: | rclsp |
| Suggests: | testthat (≥ 3.0.0) |
| Published: | 2025-12-03 |
| DOI: | 10.32614/CRAN.package.rlppinv (may not be active yet) |
| Author: | Ilya Bolotov |
| Maintainer: | Ilya Bolotov <ilya.bolotov at vse.cz> |
| BugReports: | https://github.com/econcz/rlppinv/issues |
| License: | MIT + file LICENSE |
| URL: | https://github.com/econcz/rlppinv |
| NeedsCompilation: | no |
| Language: | en-US |
| Materials: | README |
| CRAN checks: | rlppinv results |
| Reference manual: | rlppinv.html , rlppinv.pdf |
| Package source: | rlppinv_0.1.0.tar.gz |
| Windows binaries: | r-devel: not available, r-release: not available, r-oldrel: not available |
| macOS binaries: | r-release (arm64): rlppinv_0.1.0.tgz, r-oldrel (arm64): rlppinv_0.1.0.tgz, r-release (x86_64): rlppinv_0.1.0.tgz, r-oldrel (x86_64): rlppinv_0.1.0.tgz |
Please use the canonical form https://CRAN.R-project.org/package=rlppinv to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.